Episode Outline:

Insulin Prices & What To Do About It

Sky rocking cost of insulin

       -  ADA and Health Care Cost Institute – prices 2x between 2012 and 2016, 3x in decade before 2012

       -  100 year history – R&D is over – price changes are PhRMA increases

       -  Sanofi

       -  Novo Nordisk

       -  Eli Lilly

Insulins

       -  Old – Humulin, Novolin

       -  New Analog insulins – Lantus, Levemir, Novolog, Humalog – less hypoglycemia

Harvard Study

       -  Type 2 diabetes

       -  JAMA recent study

       -  Anthem patients witched from new to old insulins

       -  Outcomes:  Patients less likely to reach Med D donut hole (80% vs. 53% after the switch), no increased risk of dangerously high/low BS, no increase in ED or hospital stays

House and Senate targeting cost of insulin

       -  House Energy & Commerce Committee 

       -  Senate Finance Committee 

Options:

       -  PhRMA regulations

       -  Legalize Canadian imports – patients, wholesalers, pharmacists

       -  PhRMA self-regulation

       -  Competition from human insulins

_______

Make sure to subscribe to get the latest episode. 

Contact Us:

Email: [email protected]

Website: http://www.propharmaconsultants.com/

Facebook: https://www.facebook.com/propharmainc

Twitter: https://twitter.com/ProPharma

Instagram: https://www.instagram.com/propharmainc/

LinkedIn: https://www.linkedin.com/company/pro-pharma-pharmaceutical-consultants-inc/

Podcast: https://anchor.fm/pro-pharma-talks

YouTube: https://www.youtube.com/user/ProPharmaEducation